LODINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lodine, and when can generic versions of Lodine launch?
Lodine is a drug marketed by Wyeth Pharms Inc and is included in two NDAs.
The generic ingredient in LODINE is etodolac. There are twenty-three drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the etodolac profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lodine
A generic version of LODINE was approved as etodolac by ABRAXEOLUS on April 11th, 1997.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LODINE?
- What are the global sales for LODINE?
- What is Average Wholesale Price for LODINE?
Summary for LODINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 118 |
Patent Applications: | 4,501 |
DailyMed Link: | LODINE at DailyMed |
US Patents and Regulatory Information for LODINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wyeth Pharms Inc | LODINE | etodolac | CAPSULE;ORAL | 018922-002 | Jan 31, 1991 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Wyeth Pharms Inc | LODINE XL | etodolac | TABLET, EXTENDED RELEASE;ORAL | 020584-002 | Oct 25, 1996 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Wyeth Pharms Inc | LODINE | etodolac | TABLET;ORAL | 018922-005 | Jun 28, 1996 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Wyeth Pharms Inc | LODINE | etodolac | CAPSULE;ORAL | 018922-003 | Jan 31, 1991 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LODINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Wyeth Pharms Inc | LODINE | etodolac | CAPSULE;ORAL | 018922-002 | Jan 31, 1991 | ⤷ Sign Up | ⤷ Sign Up |
Wyeth Pharms Inc | LODINE | etodolac | CAPSULE;ORAL | 018922-003 | Jan 31, 1991 | ⤷ Sign Up | ⤷ Sign Up |
Wyeth Pharms Inc | LODINE | etodolac | TABLET;ORAL | 018922-004 | Jul 29, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Wyeth Pharms Inc | LODINE | etodolac | CAPSULE;ORAL | 018922-003 | Jan 31, 1991 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LODINE
See the table below for patents covering LODINE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Denmark | 155328 | ⤷ Sign Up | |
Sweden | 387122 | FORFARANDE FOR FRAMSTELLNING AV PYRANO(3,4-B)INDOL- ELLER TIOPYRANO(3,4-B)INDOLDERIVAT MED TERAPEUTISK VERKAN | ⤷ Sign Up |
Philippines | 11673 | A PROCESS FOR THE PREPARATION OF PYRANO(THIOPYRANO)(3,4-B)INDOLE DERIVATIVES | ⤷ Sign Up |
Philippines | 10625 | 1,3,4,9-TETRAHYDROPYRANO-OR 1,3,4,9-TETRAHYDROTHIOPYRANO-(3,4-B)INDOLE DERIVATIVES | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |